Dr. Jitendra Singh today convened a joint meeting of Department of Biotechnology, AIIMS New Delhi, BIRAC, ICMR and Industry partners here to review the indigenously developed HPV test kits for Cervical Cancer screening in India and described it as another milestone in preventive healthcare achieved by the Department of Biotechnology (DBT) under the Ministry of Science & Technology.
Dr. Jitendra Singh emphasized that the ultimate goal is to position India as a global leader in preventive healthcare. He said it is now the right time to acknowledge a series of significant milestones accomplished by the team at DBT and BIRAC, including the development of the first-ever DNA vaccine, which brought India international recognition and restored esteem to Indian science in the field of healthcare.
"The DNA vaccine has projected India as a country capable of leading in preventive healthcare—a stark contrast to the outdated perception that India neither prioritized preventive, nor even curative healthcare,” said Dr. Jitendra Singh.
Copyright © 2017 Indian Grapevine a unit of Integrated Media Enterprises
